High-tech imaging contributing to overdiagnosis of low-risk thyroid cancers

An increasing gap between the incidence of thyroid cancer and deaths from the disease suggests that low-risk cancers are being overdiagnosed and overtreated, a study from the Mayo Clinic Center for the Science of Health Care Delivery finds. The study appears in the current issue of the British Medical Journal.

"High tech imaging technologies such as ultrasound, CT and MRI can detect very small many of which are slow growing papillary thyroid cancers, says the study's lead author Juan Pablo Brito, M.B.B.S. an endocrine fellow and scholar at Mayo Clinic. "This is exposing patients to unnecessary and harmful treatments that are inconsistent with their prognosis."

Dr. Brito says the surgical removal of all or part of the is a costly procedure and includes a risk of complications such as low calcium levels and nerve injury. Surgical removal procedures in the United States have tripled in the past 30 years—from 3.6 per 100,000 people in 1973 to 11.6 per 100,000 people in 2009.

"Uncertainty about the benefits and harms of immediate treatment for low-risk should spur clinicians to engage patients in shared decision-making to ensure treatment is consistent with the research evidence and patient goals," Dr. Brito says.

To help provide context for patients, Dr. Brito recommends the development of a new term that connotes a favorable prognosis for low-risk thyroid cancers, such as microPapillary Lesions of Indolent Course (microPLIC). A new term would make it easier for clinicians to offer patients the choice of active surveillance instead of immediate and often intensive treatment. He also calls for research to identify the appropriate care for these patients.

More information: www.bmj.com/cgi/doi/10.1136/bmj.f4706

Journal information: British Medical Journal (BMJ)
Provided by Mayo Clinic
Citation: High-tech imaging contributing to overdiagnosis of low-risk thyroid cancers (2013, August 27) retrieved 28 March 2024 from https://medicalxpress.com/news/2013-08-high-tech-imaging-contributing-overdiagnosis-low-risk.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Thyroid cancer biopsy guidelines should be simplified, researchers say

 shares

Feedback to editors